| Filed On | Filing |
|---|---|
| 12 Apr 2024 |
8-K/A: Other Events
On April 9, 2024, Fusion Pharmaceuticals Inc. (the “Company”) presented a poster at the American Association for Cancer Research Annual Meeting 2024 (the “Original AACR Poster”), which showed interim efficacy and safety data from the Pha... |
| 14 Feb 2023 |
8-K/A: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities +2 more
CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT HAVE BEEN OMITTED AND REPLACED WITH “[***]”. SUCH IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS (I) NOT MATERIAL AND (II) WOULD LIKELY CAUSE COMPETITIVE HARM TO THE... |
| 23 Jul 2021 | 8-K/A: Financial Statements and Exhibits |
Loading...
